{"version":"1.0","provider_name":"3Sixty Pharma Solutions LLC","provider_url":"https:\/\/3sixtypharma.com","author_name":"Admin","author_url":"https:\/\/3sixtypharma.com\/author\/admin\/","title":"Biosimilar nomenclature: Deadline August 2 for comments on FDA’s OMB information request","type":"rich","width":600,"height":338,"html":"
Biosimilar nomenclature: Deadline August 2 for comments on FDA’s OMB information request<\/a><\/blockquote>